| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
258,976 | 251,256 | 267,781 | 239,182 | 187,924 |
| Cost of Revenue
|
-126,376 | -124,042 | -114,000 | -94,616 | -87,501 |
|
Gross Profit
|
132,600 | 127,214 | 153,781 | 144,566 | 100,423 |
| Selling, General and Administrative Expenses
|
-39,695 | -39,695 | -40,683 | -37,996 | -3,056 |
| Depreciation, Amortization and Depletion
|
-29,701 | -28,792 | -24,756 | -21,165 | -18,853 |
| Other Income/Expense, Operating
|
-- | -- | -- | -35,683 | -29,135 |
|
Operating Income/Expenses
|
-70,363 | -68,487 | -65,439 | -59,161 | -51,044 |
|
Total Operating Profit/Loss
|
62,237 | 58,727 | 88,342 | 85,405 | 49,379 |
| Total Net Finance Income/Expense
|
-387 | -1,740 | -2,353 | -3,778 | -778 |
| Net Investment Income
|
-672 | -672 | 15 | -273 | 327 |
|
Non-Operating Income/Expenses, Total
|
-1,059 | -2,412 | -2,338 | -4,051 | -451 |
|
Pretax Income
|
61,178 | 56,315 | 86,004 | 81,354 | 48,928 |
|
Provision for Income Tax
|
-14,326 | -13,193 | -21,189 | -18,176 | -10,545 |
|
Net Income from Continuing Operations
|
46,852 | 43,122 | 64,815 | 63,178 | 38,383 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
46,852 | 43,122 | 64,815 | 63,178 | 38,383 |
|
Net Income after Non-Controlling/Minority Interests
|
46,852 | 43,122 | 64,815 | 63,178 | 38,383 |
|
Net Income Available to Common Stockholders
|
46,852 | 43,122 | 64,815 | 63,178 | 38,383 |
|
Diluted Net Income Available to Common Stockholders
|
46,852 | 43,122 | 64,815 | 63,178 | 38,383 |
|
Common Dividend per Share
|
1.00 | 1.00 | 0.64 | 0.28 | 0.21 |
| Basic EPS
|
2.34 | 2.16 | 3.24 | 3.23 | 1.92 |
| Diluted EPS
|
2.34 | 2.16 | 3.24 | 3.16 | 1.92 |
|
Basic Weighted Average Shares Outstanding
|
19,559.96 | 19,559.96 | 19,562.81 | 19,560.82 | 19,560.40 |
|
Diluted Weighted Average Shares Outstanding
|
19,559.96 | 19,559.96 | 19,562.81 | 19,997.79 | 19,560.40 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
61,565 | 58,055 | 88,357 | 85,132 | 49,706 |
|
EBITDA
|
91,266 | 86,847 | 113,209 | 106,297 | 68,559 |
|
Normalized EBITDA
|
91,266 | 86,847 | 113,209 | 106,532 | 68,855 |
|
Normalized Income
|
46,852 | 43,122 | 64,815 | 63,360.60 | 38,616.25 |
|
Total Unusual Items
|
0 | 0 | 0 | 235 | 296 |
|
Total Unusual Items Excluding Goodwill
|
0 | 0 | 0 | 235 | 296 |
12/31/2022 - 2/22/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade